EQUUS TOTAL RETURN, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EQUUS TOTAL RETURN, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($18.78M) | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | $12.95M | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | ($1.13M) | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $2.59M | Dec 18, 2025 |
| FY2022 | Dec 31, 2020 | ($12.29M) | Dec 18, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $189.0K | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | $133.0K | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | $130.0K | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $140.0K | Dec 18, 2025 |
| FY2022 | Dec 31, 2020 | $168.0K | Dec 18, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $38.23M | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | ($51.36M) | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | ($7.70M) | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $21.11M | Dec 18, 2025 |
| FY2022 | Dec 31, 2020 | $24.61M | Dec 18, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $29.94M | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | $93.55M | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | $41.66M | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $39.72M | Dec 18, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $426.0K | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | $45.26M | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | $6.43M | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $3.35M | Dec 18, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $36.37M | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | $48.29M | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | $35.24M | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $36.37M | Dec 18, 2025 |
| FY2022 | Dec 31, 2020 | $33.78M | Dec 18, 2025 |
| FY2022 | Dec 31, 2019 | $45.99M | Dec 18, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($45.29M) | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | ($26.51M) | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | ($39.46M) | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | ($38.33M) | Dec 18, 2025 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $262.0K | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | $6.53M | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | $19.22M | Dec 18, 2025 |
| FY2022 | Sep 30, 2022 | $19.22M | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | $23.47M | Dec 18, 2025 |
| FY2022 | Dec 31, 2020 | $23.64M | Dec 18, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (1) | Dec 17, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Dec 17, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Dec 17, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | 0 | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Dec 18, 2025 |
| FY2022 | Dec 31, 2020 | 0 | Dec 18, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 13.59M | Dec 17, 2025 |
| FY2023 | Dec 31, 2023 | 13.59M | Dec 18, 2025 |
| FY2022 | Dec 31, 2022 | 13.52M | Dec 18, 2025 |
| FY2022 | Dec 31, 2021 | 13.52M | Dec 18, 2025 |